Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements
Portfolio Pulse from Happy Mohamed
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. The company had previously been notified by Nasdaq that it was not in compliance due to its common stock failing to meet the closing bid price of $1.00 or more for 30 consecutive business days. The requirement was met on June 26, 2023.
June 28, 2023 | 12:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Creative Medical Technology Holdings has regained compliance with Nasdaq's minimum bid price requirement, which could potentially boost investor confidence in the company.
Regaining compliance with Nasdaq's minimum bid price requirement is a positive development for Creative Medical Technology Holdings. It removes the risk of delisting, which can negatively impact a company's reputation and investor confidence. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100